Kostas Trakas

• Developed and executed a comprehensive strategic plan aligned with the company's mission and vision, focusing on real-world evidence generation in the field of oncology
• Articulated a compelling vision for the company to potential investors, partners, and internal teams, driving enthusiasm and commitment
• Led the executive team in decision-making regarding key strategic priorities and resource allocation
• Recruited, developed, and retained a high-performing team across key functions including scientific affairs, data operations, platform technology, and business development
• Foster a collaborative and results-oriented culture within the organization
• Shifted organization from a grant-based to a revenue-based financing model
• Actively engaged governments, government agencies, and intergovernmental organizations
• Built a network within the investment community to identify potential investors

• Company Overview: At Noviscend, our vision was to accelerate access and adoption of leading-edge innovative medical products and technologies in the Canadian market
• Partnered with strategic investors, policymakers and innovators to bring scalable and sustainable solutions to our healthcare ecosystem
• Finalized agreement for distribution of Myriad Genetics tests in the Canadian market.
• Completed the acquisition of Iris Technological Designs and the associated IP portfolio
• Led collaboration with Launch It Ventures, co-created initial commercial product.

• Company Overview: A global consultancy helping healthcare companies in need of transforming their business models to remain competitive in today's rapidly changing landscape.
• Personalized Medicine Models.
• Market Access Strategy, including pricing, dossier development, and reimbursement submissions.

• Founded Nutu Inc. With the mission to promote better health through daily lifestyle choices.
• Nutu aspired to nudge patients into making better choices by making healthy habits almost addictive.
• Designed and developed an interactive platform concept for the Kinetic Corps game.
• Led the team to build an MVP for user testing and market research.
• Launched MVP to iOS and Google App stores for initial user feedback.

• Global commercial lead for Janssen interferon-free development and strategic marketing strategies
• Lead the development of novel business models to differentiate hepatitis C launches in US and Europe including: innovative financing models, integrated care models, diagnostics, and advocacy

Janssen Healthcare Innovation (JHI)

• Responsible for the identification of novel partnering opportunities within the healthcare ecosystem.
• Helped develop and establish a governance model for JHI.
  

Janssen Diagnostics

• Development of value propositions for lead companion opportunities, capturing the strategic impact of novel biomarkers and diagnostics.
• Development of a market access framework for application to all future companion diagnostic opportunities.
• Co-developed J&J's diagnostics policy platform, and engaged with stakeholders to shape legislation, such as the 21st Century Cures Act.

• Goal: Determine opportunities to implement novel access models in support of J&J products
• Results: Developed two Public-Private-Partnership models that were subsequently implemented in the EMEA and LATAM regions